• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非囊性纤维化支气管扩张症患者痰液中分离出曲霉菌和念珠菌的患病率及相关因素

Prevalence and factors associated with isolation of Aspergillus and Candida from sputum in patients with non-cystic fibrosis bronchiectasis.

作者信息

Máiz Luis, Vendrell Montserrat, Olveira Casilda, Girón Rosa, Nieto Rosa, Martínez-García Miguel Ángel

机构信息

Pneumology Service, Hospital Universitario Ramón y Cajal, Madrid, Spain.

出版信息

Respiration. 2015;89(5):396-403. doi: 10.1159/000381289. Epub 2015 Apr 23.

DOI:10.1159/000381289
PMID:25924628
Abstract

BACKGROUND

Information on the role of fungi in non-cystic fibrosis (CF) bronchiectasis is lacking.

OBJECTIVES

Our aim was to determine the prevalence of and factors associated with the isolation and persistence of fungi from sputum in these patients.

METHODS

We performed a multicenter observational study comprising adult patients with non-CF bronchiectasis. Persistence of Aspergillus spp. and Candida albicans was defined as the presence of ≥2 positive sputum cultures taken at least 6 months apart within a period of 5 years.

RESULTS

A total of 252 patients (62.7% women with a mean ± SD age of 55.3 ± 16.7 years) were included in the study. All patients had at least 1 sputum sample cultured for fungi, with a mean ± SD of 7 ± 6 cultures per patient. Eighteen (8.7%) and 71 (34.5%) patients had persistent positive cultures for Aspergillus spp. and C. albicans, respectively. Patients with persistence of Aspergillus spp. and C. albicans were older and had more daily purulent sputum. In addition, patients with persistent C. albicans had worse postbronchodilator forced expiratory volume in the first second (FEV1), more frequent cystic bronchiectasis, and more hospital-treated exacerbations. They were also more frequently treated with long-term antibiotics. Multivariate analysis showed that daily purulent sputum (OR = 3.75, p = 0.045) and long-term antibiotics (OR = 2.37, p = 0.005) were independently associated with persistence of Aspergillus spp. and C. albicans, respectively.

CONCLUSIONS

Isolation and persistence of Aspergillus spp. and C. albicans are frequent in patients with non-CF bronchiectasis. Daily purulent sputum and chronic antibiotic treatment were associated with persistence of Aspergillus spp. and C. albicans, respectively.

摘要

背景

关于真菌在非囊性纤维化(CF)支气管扩张症中的作用,目前尚缺乏相关信息。

目的

我们的目的是确定这些患者痰液中真菌分离及持续存在的患病率和相关因素。

方法

我们开展了一项多中心观察性研究,纳入了患有非CF支气管扩张症的成年患者。曲霉属和白色念珠菌的持续存在定义为在5年内至少间隔6个月采集到≥2次阳性痰培养结果。

结果

共有252例患者(62.7%为女性,平均年龄±标准差为55.3±16.7岁)纳入研究。所有患者至少有1份痰样本进行了真菌培养,每位患者平均培养次数±标准差为7±6次。分别有18例(8.7%)和71例(34.5%)患者曲霉属和白色念珠菌培养持续阳性。曲霉属和白色念珠菌持续存在的患者年龄更大,每日脓性痰更多。此外,白色念珠菌持续存在的患者支气管扩张剂使用后第1秒用力呼气量(FEV1)更差,囊性支气管扩张更频繁,因病情加重住院治疗的次数更多。他们接受长期抗生素治疗的频率也更高。多因素分析显示,每日脓性痰(比值比[OR]=3.75,p=0.045)和长期抗生素治疗(OR=2.37,p=0.005)分别与曲霉属和白色念珠菌的持续存在独立相关。

结论

非CF支气管扩张症患者中曲霉属和白色念珠菌的分离及持续存在较为常见。每日脓性痰和长期抗生素治疗分别与曲霉属和白色念珠菌的持续存在相关。

相似文献

1
Prevalence and factors associated with isolation of Aspergillus and Candida from sputum in patients with non-cystic fibrosis bronchiectasis.非囊性纤维化支气管扩张症患者痰液中分离出曲霉菌和念珠菌的患病率及相关因素
Respiration. 2015;89(5):396-403. doi: 10.1159/000381289. Epub 2015 Apr 23.
2
A 16-year retrospective study on fungal prevalence and diversity in patients with cystic fibrosis: Candida dubliniensis was associated with a decline in lung function.一项关于囊性纤维化患者真菌流行率和多样性的 16 年回顾性研究:杜伦念珠菌与肺功能下降相关。
Int J Infect Dis. 2020 Jul;96:663-670. doi: 10.1016/j.ijid.2020.05.063. Epub 2020 May 22.
3
IgE-mediated immune responses and airway detection of Aspergillus and Candida in adult cystic fibrosis.成人囊性纤维化中曲霉属和假丝酵母属的 IgE 介导免疫反应和气道检测
Chest. 2013 May;143(5):1351-1357. doi: 10.1378/chest.12-1363.
4
The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.囊性纤维化患儿肺曲霉病的临床表现——初步报告
Dev Period Med. 2015 Jan-Mar;19(1):66-79.
5
Intravenous antibiotics reduce the presence of Aspergillus in adult cystic fibrosis sputum.静脉用抗生素可减少成人囊性纤维化痰液中烟曲霉的存在。
Thorax. 2013 Jul;68(7):652-7. doi: 10.1136/thoraxjnl-2012-202412. Epub 2013 Mar 19.
6
Sputum Candida albicans presages FEV₁ decline and hospital-treated exacerbations in cystic fibrosis.白色念珠菌痰预示着囊性纤维化患者的 FEV₁ 下降和需要住院治疗的加重。
Chest. 2010 Nov;138(5):1186-95. doi: 10.1378/chest.09-2996. Epub 2010 May 14.
7
Candida albicans chronic colonisation in cystic fibrosis may be associated with inhaled antibiotics.白色念珠菌在囊性纤维化患者中的慢性定植可能与吸入性抗生素有关。
Mycoses. 2015 Jul;58(7):416-21. doi: 10.1111/myc.12338. Epub 2015 Jun 9.
8
The fungal airway microbiome in cystic fibrosis and non-cystic fibrosis bronchiectasis.囊性纤维化和非囊性纤维化支气管扩张症的真菌气道微生物组。
J Cyst Fibros. 2021 Mar;20(2):295-302. doi: 10.1016/j.jcf.2020.05.013. Epub 2020 Jun 13.
9
Pseudomonas aeruginosa, cyanide accumulation and lung function in CF and non-CF bronchiectasis patients.囊性纤维化(CF)和非囊性纤维化支气管扩张症患者中的铜绿假单胞菌、氰化物蓄积与肺功能
Eur Respir J. 2008 Sep;32(3):740-7. doi: 10.1183/09031936.00159607. Epub 2008 May 14.
10
Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial.吸入性甘露醇治疗非囊性纤维化支气管扩张症:一项随机对照试验。
Thorax. 2014 Dec;69(12):1073-9. doi: 10.1136/thoraxjnl-2014-205587. Epub 2014 Sep 21.

引用本文的文献

1
Diagnostic Value of Microscopy, Galactomannan, and PCR in Aspergillus Culture-Positive BALF Samples: A Laboratory-Based Pilot Study.显微镜检查、半乳甘露聚糖和聚合酶链反应在曲霉培养阳性支气管肺泡灌洗样本中的诊断价值:一项基于实验室的初步研究。
Mycoses. 2025 Aug;68(8):e70103. doi: 10.1111/myc.70103.
2
Shifting sands: Unveiling the changes in respiratory comorbidities and fungal pathogens in Saudi Arabia.变幻莫测:揭示沙特阿拉伯呼吸道合并症和真菌病原体的变化
Saudi Med J. 2025 Feb;46(2):182-189. doi: 10.15537/smj.2025.46.2.20240616.
3
Changes in the airway microbiome in patients with bronchiectasis.
支气管扩张症患者气道微生物组的变化。
Medicine (Baltimore). 2023 Dec 15;102(50):e36519. doi: 10.1097/MD.0000000000036519.
4
Frequency and Distribution of Broncho-Alveolar Fungi in Lung Diseases in Martinique.马提尼克岛肺部疾病中支气管肺泡真菌的频率与分布
J Clin Med. 2023 Aug 24;12(17):5480. doi: 10.3390/jcm12175480.
5
Effect of Flagellin Pre-Exposure on the Inflammatory and Antifungal Response of Bronchial Epithelial Cells to Fungal Pathogens.鞭毛蛋白预暴露对支气管上皮细胞针对真菌病原体的炎症和抗真菌反应的影响。
J Fungi (Basel). 2022 Nov 30;8(12):1268. doi: 10.3390/jof8121268.
6
Clinical Signatures in COPD and Bronchiectasis.慢性阻塞性肺疾病和支气管扩张症的临床特征
J Fungi (Basel). 2022 May 5;8(5):480. doi: 10.3390/jof8050480.
7
Impacts of Nontuberculous Mycobacteria Isolates in Non-cystic Fibrosis Bronchiectasis: A 16-Year Cohort Study in Taiwan.非结核分枝杆菌分离株对非囊性纤维化支气管扩张症的影响:台湾一项为期16年的队列研究
Front Microbiol. 2022 Apr 18;13:868435. doi: 10.3389/fmicb.2022.868435. eCollection 2022.
8
The Human Mycobiome in Chronic Respiratory Diseases: Current Situation and Future Perspectives.慢性呼吸道疾病中的人类真菌微生物组:现状与未来展望
Microorganisms. 2022 Apr 13;10(4):810. doi: 10.3390/microorganisms10040810.
9
-Host Interactions Mediating Airway Wall Remodelling in Asthma.-介导哮喘气道壁重塑的宿主相互作用。
J Fungi (Basel). 2022 Feb 6;8(2):159. doi: 10.3390/jof8020159.
10
Striking Back against Fungal Infections: The Utilization of Nanosystems for Antifungal Strategies.抗击真菌感染:纳米系统在抗真菌策略中的应用。
Int J Mol Sci. 2021 Sep 18;22(18):10104. doi: 10.3390/ijms221810104.